Picture of Clariane SE logo

CLARI Clariane SE Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapTurnaround

Annual cashflow statement for Clariane SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2020
December 31st
C2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line42.112245-80.3-26.9
Depreciation
Non-Cash Items266231246242250
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-37.4-125-46.9-108-26.5
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities795840862804900
Capital Expenditures-520-529-622-484-308
Purchase of Fixed Assets
Other Investing Cash Flow Items-577-296-148-185356
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-1,097-825-770-67047.7
Financing Cash Flow Items-1836.71-215-174-377
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,11231.4-550-194-1,107
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash81050.3-465-57.7-159